Keylika YC 申请

Summer 2022Active

Keylika 在 Summer 2022 批次的 Y Combinator 中作为一家 Healthcare 公司进行过。以下是：公司做什么、谁创立了它，以及其 YC 申请，按照真实 YC 表格逐题重建。

YC 批次: Summer 2022
行业: HealthcareTherapeutics
团队规模: 1
状态: Active
已发布: 2022

创始人

Buddha ChaudhuriFounder
Frederik CeyssensFounder

Keylika 做什么

Keylika is an early stage biopharma startup developing metal-based drugs using a platform synthesis technology to treat unmet medical needs. We then administer these drugs using proven delivery technologies to effect the best clinical outcomes. Our first product is a small molecule iron drug (new molecular entity) delivered by a wearable skin patch to treat Iron Deficiency Anemia (IDA), with significantly higher safety, efficacy and tolerability over existing treatments. This is poised to be a best-in-class, potentially breakthrough therapy for treating iron deficiency without any GI side-effects (eg. nausea, constipation, diarrhea, etc.) typically associated with oral iron supplements, and without the risks, costs and side-effects associated with IV iron infusions. When approved, Keylika’s proprietary transdermal iron will be the world's first prescription iron patch. Iron deficiency is a hugely understated problem affecting about 1.6 billion people worldwide and more than 30 million in the US alone, translating to a $17B US market.

Keylika 的 YC 申请，重建版

Y Combinator 申请

Keylika，Summer 2022 期。来自公开数据的真实申请问题解答。

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Keylika

Describe what your company does in 50 characters or less.

Redefining the Standard of Care for Iron Deficiency Anemia

What is your company going to make? Please describe your product and what it does or will do.

We develop metal-based drugs using our platform synthesis technology and deliver them via proven methods. Our first product is a wearable skin patch that delivers a new molecular iron drug for Iron Deficiency Anemia with fewer side effects than oral or IV treatments.

Where do you live now, and where would the company be based after YC?

We live in Walnut Creek, CA, and plan to keep the company based here after YC.

Explain your decision regarding location.

We are already based in Walnut Creek near the Bay Area's biotech and healthcare ecosystem, which suits our access to talent and partners.

21 更多回答在完整申请中

Founders, Progress, Idea, Equity, Curious, Batch Preference 包含在完整版中。创建免费账户即可在 YC Insights 中打开，紧邻每个其他 YC 批次。

查看完整申请

常见问题解答

这是 Keylika 的真实 YC 申请吗？

不是。Y Combinator 对提交的申请保密。这是重建版：使用 Keylika 的公开数据（发布笔记、创始人背景、产品描述）回答真实的 YC 表格问题。它展示了像 Keylika 这样的公司会如何向 YC 自我介绍，而不是他们提交的文本。

Keylika 是哪个 YC 批次的？

Keylika 是 Y Combinator Summer 2022 批次的成员。

谁创立了 Keylika？

Keylika 由 Buddha Chaudhuri, Frederik Ceyssens 创立。

Keylika 做什么？